These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19831278)

  • 1. Preparation and characterization of etoricoxib-polyethylene glycol 4000 plus polyvinylpyrrolidone K30 solid dispersions.
    Suhagia BN; Patel HM; Shah SA; Rathod I; Parmar VK
    Acta Pharm; 2006 Sep; 56(3):285-98. PubMed ID: 19831278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Processing of nimesulide-PEG 400-PG-PVP solid dispersions: preparation, characterization, and in vitro dissolution.
    Gohel MC; Patel LD
    Drug Dev Ind Pharm; 2003 Mar; 29(3):299-310. PubMed ID: 12741611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.
    Patel RP; Patel MM
    Pharm Dev Technol; 2007; 12(1):21-33. PubMed ID: 17484141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
    Patil MP; Gaikwad NJ
    Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced solubility of piperine using hydrophilic carrier-based potent solid dispersion systems.
    Thenmozhi K; Yoo YJ
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1501-1509. PubMed ID: 28425323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.
    Sethia S; Squillante E
    Int J Pharm; 2004 Mar; 272(1-2):1-10. PubMed ID: 15019063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and solubility study of norfloxacin-polyethylene glycol, polyvinylpyrrolidone and carbopol 974p solid dispersions.
    Gorajana A; Kit WW; Dua K
    Recent Pat Drug Deliv Formul; 2015; 9(2):167-82. PubMed ID: 25714525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H; Fussnegger B; Bodmeier R
    Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, characterization and tableting of cilnidipine solid dispersions.
    Hu L; Song W; Niu F; Jiao K; Jia Z
    Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion.
    Sammour OA; Hammad MA; Megrab NA; Zidan AS
    AAPS PharmSciTech; 2006 Jun; 7(2):E55. PubMed ID: 16796372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of solid dispersions of β-lapachone in PEG and PVP by solvent evaporation method.
    Dos Santos KM; Barbosa RM; Vargas FGA; de Azevedo EP; Lins ACDS; Camara CA; Aragão CFS; Moura TFLE; Raffin FN
    Drug Dev Ind Pharm; 2018 May; 44(5):750-756. PubMed ID: 29206496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical characterization of artemether solid dispersions with hydrophilic carriers by freeze dried and melt methods.
    Ansari MT; Karim S; Ranjha NM; Shah NH; Muhammad S
    Arch Pharm Res; 2010 Jun; 33(6):901-10. PubMed ID: 20607495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of etoricoxib solid dispersions using lipid carriers by spray drying technique.
    Chauhan B; Shimpi S; Paradkar A
    AAPS PharmSciTech; 2005 Oct; 6(3):E405-12. PubMed ID: 16353998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique.
    Shinde VR; Shelake MR; Shetty SS; Chavan-Patil AB; Pore YV; Late SG
    J Pharm Pharmacol; 2008 Sep; 60(9):1121-9. PubMed ID: 18718114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solubility advantage from amorphous etoricoxib solid dispersions.
    Dani P; Puri V; Bansal AK
    Drug Dev Ind Pharm; 2014 Jan; 40(1):92-101. PubMed ID: 23301771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the dissolution profile of allopurinol by a solid dispersion technique.
    Samy AM; Marzouk MA; Ammar AA; Ahmed MK
    Drug Discov Ther; 2010 Apr; 4(2):77-84. PubMed ID: 22491164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets.
    Srinarong P; Kouwen S; Visser MR; Hinrichs WL; Frijlink HW
    Pharm Dev Technol; 2010; 15(5):460-8. PubMed ID: 20735300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preparation and dissolution in vitro of esomeprazole zinc solid dispersion].
    Xie P; Xie YM; Song H; Song X; Zuo YJ; Qiu Y; Tang XH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):648-50. PubMed ID: 18798516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier.
    Yin LF; Huang SJ; Zhu CL; Zhang SH; Zhang Q; Chen XJ; Liu QW
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1371-80. PubMed ID: 22296267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing the ability of PVP/PEG mixtures to be used as appropriate carriers for the preparation of drug solid dispersions by melt mixing technique using artificial neural networks: I.
    Papadimitriou SA; Barmpalexis P; Karavas E; Bikiaris DN
    Eur J Pharm Biopharm; 2012 Sep; 82(1):175-86. PubMed ID: 22732266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.